Belgium · 
Who invested in Augustine Therapeutics?
Augustine Therapeutics's investors include Novo Holdings and Eli Lilly.
Belgium · Series A startup
Who invested in Augustine Therapeutics
Funding summaryUpdated 26 Oct 2026
$84Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $84MMar 2025
- Investors
- 2
The rounds
- Mar 2025
Founders and team
From Augustine Therapeutics's own website: 2 on the team.
- Virginie CartageChief Financial Officer
- Pascale WitzBoard Chair
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Augustine Therapeutics
How much has Augustine Therapeutics raised?
Augustine Therapeutics has raised $84M across 1 round since 2025.
When did Augustine Therapeutics last raise?
Augustine Therapeutics's most recent round was a Series A of $84M in Mar 2025.
What was Augustine Therapeutics's biggest round?
Its most recent round, $84M in Mar 2025, is also its largest on record.
Who backed Augustine Therapeutics first?
Augustine Therapeutics's first round on record, in Mar 2025, was backed by Novo Holdings and Eli Lilly.
What stage is Augustine Therapeutics at?
Augustine Therapeutics's latest named round is a Series A, in Mar 2025.
Where is Augustine Therapeutics based?
Augustine Therapeutics is based in Belgium.
Companies like Augustine Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.